In a U-turn, the UK's CMA provisionally agrees to the $8B merger between Avast and NortonLifeLock, citing “significant competition” from McAfee and others
Avast shares rise more than 40% after CMA provisionally agrees $8bn merger with US rival
Context & Ripple Effects
The CMA's provisional clearance reverses its own March position, when it warned the $8.6B acquisition could leave customers worse off and demanded remedy proposals. The turnaround rests on a market-structure argument: with McAfee and other vendors holding 'significant competition', the combined NortonLifeLock-Avast no longer looks dominant.
The deal itself dates to NortonLifeLock's 2021 cash-and-stock merger agreement, built on Avast's earlier roll-up of AVG and NortonLifeLock's purchase of Avira — consolidation that regulators initially flagged as the very source of the competition concern.
First-order effects
- Avast shareholders capture the value immediately: shares jumped more than 40% on the news, recovering much of the discount the deal had traded at since the CMA's March intervention.
- NortonLifeLock moves from regulatory limbo to a probable close of an $8B+ merger that had been pending since mid-2021, with the CMA's final decision now the remaining gate.
Second-order effects
- McAfee is elevated from also-ran to the regulator's load-bearing competitor — its pricing and product decisions now effectively define how much room the merged consumer-security giant has to raise prices without re-triggering scrutiny.
- Rival antivirus vendors face a consolidated competitor combining Norton, Avast and Avira brands, pressuring them toward their own bundling or M&A responses to defend shelf space and subscription renewals.
Third-order effects
- If the CMA's logic holds — that a market with several credible paid-security vendors can absorb brand consolidation — expect UK merger review to lean on remedy proposals and market-definition arguments rather than outright blocks in mature software categories.
- Consumer cybersecurity keeps consolidating around multi-brand portfolios, shifting competition policy's focus from counting brands to measuring actual switching behavior between security subscriptions.
The trend: Consumer antivirus is consolidating into multi-brand portfolios while regulators increasingly clear deals by citing remaining competitors rather than blocking them outright.